Literature DB >> 6993707

Rapid serum lidocaine determination in the coronary care unit.

S M Deglin, J M Deglin, J Wurtzbacher, M Litton, C Rolfe, C McIntire.   

Abstract

Eighty-four serum lidocaine determinations were made in 33 hospitalized patients with the use of a rapid enzyme innumoassay technique. Prediction of lidocaine concentration within broad categories based on clinical assessment alone was compared with actual measurements. When serum concentrations were not considered, most episodes of lidocaine toxic reactions were obscured by associated complex clinical problems. The rapid lidocaine enzyme immunoassay is a useful tool for assisting in the detection of lidocaine toxic reactions in the coronary care unit.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993707

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Pitfalls and perils of intravenous lidocaine.

Authors:  C A Bryant; J R Hoffman; L S Nichter
Journal:  West J Med       Date:  1983-10

2.  Recurrent ventricular fibrillation after subarachnoid haemorrhage. Dose-related effect of lidocaine infusion.

Authors:  D Pinciroli; M Moretti; G Landi; M C Giusti
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

3.  alpha 1-Acid glycoprotein and plasma lidocaine binding.

Authors:  D G Shand
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

Review 4.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

Review 5.  The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.

Authors:  S Nattel; G Gagne; M Pineau
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.